14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
EXP vs CX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Eagle Materials, Inc. (EXP) captures the overall head-to-head institutional edge over Cemex S.A.B. de C.V. (CX) on higher Unified Composite conviction (38.7/100 SELL vs. 35.7/100 SELL) after splitting the core matrix 6–4 (led by Profitability & Quality, Balance Sheet & Cash Flow), while CX wins 3–2 across the 6-pillar growth and valuation breakdown. EXP trades at $172.25 (13.6x Forward P/E, 21.8% operating margin) versus CX at $9.28 (10.4x Forward P/E, 13.3% operating margin).
Growth vs. Quality Trade-Off: EXP earns the overall head-to-head edge with a stronger Unified Composite Score (38.7/100 SELL vs. CX 35.7/100 SELL) and 0.91β · 40% Vol risk profile, whereas CX leads top-line expansion (+8.1% YoY revenue growth, 0.11x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Defensive Composite Rating Caution: Although EXP compares more favorably head-to-head, both EXP (38.7/100 SELL) and CX (35.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: EXP is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.0); meanwhile CX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EXP vs CX. Trailing 12-month operating profitability (EXP 21.8% vs CX 13.3%) and valuation multiples (EXP 13.6x vs CX 10.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Building Materials value chain with $13.6B market capitalization and 13.3% operating margin.
OpEx & R&D Reinvestment20.2% of Rev ($1.30B)
90D Engineering Disclosures0 Published
Investor FAQ EXP vs CX Key Questions & Quantitative Answers
As of Nov 20, 2026, Eagle Materials, Inc. (EXP) captures the overall head-to-head institutional edge over Cemex S.A.B. de C.V. (CX) on higher Unified Composite conviction (38.7/100 SELL vs. 35.7/100 SELL) after splitting the core matrix 6–4 (led by Profitability & Quality, Balance Sheet & Cash Flow), while CX wins 3–2 across the 6-pillar growth and valuation breakdown. EXP trades at $172.25 (13.6x Forward P/E, 21.8% operating margin) versus CX at $9.28 (10.4x Forward P/E, 13.3% operating margin). Growth vs. Quality Trade-Off: EXP earns the overall head-to-head edge with a stronger Unified Composite Score (38.7/100 SELL vs. CX 35.7/100 SELL) and 0.91β · 40% Vol risk profile, whereas CX leads top-line expansion (+8.1% YoY revenue growth, 0.11x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although EXP compares more favorably head-to-head, both EXP (38.7/100 SELL) and CX (35.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: EXP is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.0); meanwhile CX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CX leads the Growth & Scale pillar: EXP posts +2.2% YoY revenue growth and -14.2% YoY earnings growth on $2.34B TTM revenue (25.8% gross margin, 21.8% operating margin), compared with CX at +8.1% YoY revenue growth and +55.4% YoY earnings growth on $6.41B TTM revenue (33.5% gross margin, 13.3% operating margin). On trailing 12-month operating scale, EXP generates $2.34B in USD-normalized revenue versus $6.41B for CX. In operating R&D and SG&A reinvestment, EXP deploys 4.0% of Rev ($94M) (0 90-day corporate R&D disclosures) versus 20.2% of Rev ($1.30B) (0 disclosures) for CX.
CX screens cheaper on headline valuation multiples. EXP trades at 13.6x Forward P/E, 14.4x Trailing P/E, 2.09x PEG, and 2.3x EV/Revenue (28.8% EBITDA margin), whereas CX trades at 10.4x Forward P/E, 58.9x Trailing P/E, 0.11x PEG, and 2.1x EV/Revenue (19.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EXP (24.5% ROE) versus CX (5.2% ROE) capital efficiency.
In options market volatility and institutional positioning, EXP carries 28.8% implied volatility (16th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.91β · 40% Vol realized risk). By comparison, CX carries 34.4% implied volatility (70th %ile, Elevated (60th–80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.30β · 36% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.